Reduced plasma phosphatidylethanolamines in e-cigarette, or vaping, product use-associated lung injury (EVALI)

Pediatr Pulmonol. 2022 May;57(5):1350-1354. doi: 10.1002/ppul.25874. Epub 2022 Mar 9.

Matthew D McGraw^{1

2}, Daniel P Croft³, Nicholas E Nacca⁴, Irfan Rahman²

¹ Department of Pediatrics, Division of Pediatric Pulmonology, University of Rochester Medical Center, Rochester, New York, USA.
² Department of Environmental Medicine, University of Rochester Medical Center, Rochester, New York, USA.
³ Department of Medicine, Division of Pulmonary Critical Care, University of Rochester Medical Center, Rochester, New York, USA.
⁴ Department of Toxicology, University of Rochester Medical Center, Rochester, New York, USA.

No abstract available

Keywords: EVALI; e-cigarette; lung; phosphatidylethanolamines; plasmalogens.

Publication types